Evidence map›Paper›PMID 33042265›Full record

ArticleTheranostics2020

Ultrasound-triggered therapeutic microbubbles enhance the efficacy of cytotoxic drugs by increasing circulation and tumor drug accumulation and limiting bioavailability and toxicity in normal tissues.

Nicola Ingram, Laura E McVeigh, Radwa H Abou-Saleh, Juliana Maynard, Sally A Peyman, James R McLaughlan, Michael Fairclough, Gemma Marston, Elizabeth M A Valleley, Jorge L Jimenez-Macias and 18 more

Open access · goldAbstract read
In one paragraph

Article in Theranostics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 1 pooled it
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 1 synthesis or guideline pooled it, 62 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Biofilm · 2025
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors at 4 institutions in 2 countries.

Nicola IngramLeeds Institute of Medical Research, Wellcome Trust Brenner Building, St James's University Hospital, Leeds, LS9 7TF, United Kingdom.
Laura E McVeighLeeds Institute of Medical Research, Wellcome Trust Brenner Building, St James's University Hospital, Leeds, LS9 7TF, United Kingdom.
Radwa H Abou-SalehMolecular and Nanoscale Physics Group, School of Physics and Astronomy, University of Leeds, LS2 9JT, United Kingdom.
Juliana MaynardMedicines Discovery Catapult, Mereside, Alderley Park, Macclesfield, SK10 4TG, United Kingdom.
Sally A PeymanMolecular and Nanoscale Physics Group, School of Physics and Astronomy, University of Leeds, LS2 9JT, United Kingdom.
James R McLaughlanFaculty of Electronic and Electrical Engineering, University of Leeds, LS2 9JT, United Kingdom.
Michael FaircloughWolfson Molecular Imaging Centre, University of Manchester, Palatine Road, Manchester, M20 3LI, United Kingdom.
Gemma MarstonLeeds Institute of Medical Research, Wellcome Trust Brenner Building, St James's University Hospital, Leeds, LS9 7TF, United Kingdom.
Elizabeth M A ValleleyLeeds Institute of Medical Research, Wellcome Trust Brenner Building, St James's University Hospital, Leeds, LS9 7TF, United Kingdom.
Jorge L Jimenez-MaciasLeeds Institute of Medical Research, Wellcome Trust Brenner Building, St James's University Hospital, Leeds, LS9 7TF, United Kingdom.
Antonia CharalambousLeeds Institute of Medical Research, Wellcome Trust Brenner Building, St James's University Hospital, Leeds, LS9 7TF, United Kingdom.
William TownleyMedicines Discovery Catapult, Mereside, Alderley Park, Macclesfield, SK10 4TG, United Kingdom.
Malcolm HaddrickMedicines Discovery Catapult, Mereside, Alderley Park, Macclesfield, SK10 4TG, United Kingdom.
Antonia WierzbickiInstitute of Cancer Therapeutics, University of Bradford, BD7 1DP, United Kingdom.
Alexander WrightLeeds Institute of Medical Research, Wellcome Trust Brenner Building, St James's University Hospital, Leeds, LS9 7TF, United Kingdom.
Milène VolpatoLeeds Institute of Medical Research, Wellcome Trust Brenner Building, St James's University Hospital, Leeds, LS9 7TF, United Kingdom.
Peter B SimpsonMedicines Discovery Catapult, Mereside, Alderley Park, Macclesfield, SK10 4TG, United Kingdom.
Darren E TreanorLeeds Institute of Medical Research, Wellcome Trust Brenner Building, St James's University Hospital, Leeds, LS9 7TF, United Kingdom.
Neil H ThomsonSchool of Dentistry, Wellcome Trust Brenner Building, St. James's University Hospital, Leeds, LS9 7TF, United Kingdom.
Paul M LoadmanInstitute of Cancer Therapeutics, University of Bradford, BD7 1DP, United Kingdom.
Richard J BushbyMolecular and Nanoscale Physics Group, School of Physics and Astronomy, University of Leeds, LS2 9JT, United Kingdom.
Benjamin R G JohnsonMolecular and Nanoscale Physics Group, School of Physics and Astronomy, University of Leeds, LS2 9JT, United Kingdom.
Pamela F JonesLeeds Institute of Medical Research, Wellcome Trust Brenner Building, St James's University Hospital, Leeds, LS9 7TF, United Kingdom.
J Anthony EvansLeeds Institute of Medical Research, Wellcome Trust Brenner Building, St James's University Hospital, Leeds, LS9 7TF, United Kingdom.
Steven FreearFaculty of Electronic and Electrical Engineering, University of Leeds, LS2 9JT, United Kingdom.
Alexander F MarkhamLeeds Institute of Medical Research, Wellcome Trust Brenner Building, St James's University Hospital, Leeds, LS9 7TF, United Kingdom.
Stephen D EvansMolecular and Nanoscale Physics Group, School of Physics and Astronomy, University of Leeds, LS2 9JT, United Kingdom.
P Louise ColettaLeeds Institute of Medical Research, Wellcome Trust Brenner Building, St James's University Hospital, Leeds, LS9 7TF, United Kingdom.
Wellcome Trust · GBUniversity of Leeds · GBSt James's University Hospital · GBMansoura University · EG

Funding

Medical Research Council MC_PC_13066Medical Research Council MR/L01629X/1
6 · The paper itself

Abstract

Most cancer patients receive chemotherapy at some stage of their treatment which makes improving the efficacy of cytotoxic drugs an ongoing and important goal. Despite large numbers of potent anti-cancer agents being developed, a major obstacle to clinical translation remains the inability to deliver therapeutic doses to a tumor without causing intolerable side effects. To address this problem, there has been intense interest in nanoformulations and targeted delivery to improve cancer outcomes. The aim of this work was to demonstrate how vascular endothelial growth factor receptor 2 (VEGFR2)-targeted, ultrasound-triggered delivery with therapeutic microbubbles (thMBs) could improve the therapeutic range of cytotoxic drugs.

Indexed as

Ultrasonic WavesAntineoplastic AgentsBiological AvailabilityCell Line, TumorColorectal NeoplasmsCombined Modality TherapyDrug Delivery SystemsFemaleHumansIrinotecanMicrobubblesMicrofluidic Analytical TechniquesPositron-Emission TomographyTissue DistributionVascular Endothelial Growth Factor Receptor-2Xenograft Model Antitumor AssaysAntineoplastic AgentsIrinotecanKDR protein, humanVascular Endothelial Growth Factor Receptor-2colorectal cancerMicrobubblenanoformulationultrasoundVEGFR2

Identifiers

PMID33042265
PMCPMC7532679
OpenAlexW3083994829

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.